187 related articles for article (PubMed ID: 36582611)
21. Overground versus treadmill walking in Parkinson's disease: Relationship between speed and spatiotemporal gait metrics.
Lu C; Louie KH; Twedell EL; Vitek JL; MacKinnon CD; Cooper SE
Gait Posture; 2022 Mar; 93():96-101. PubMed ID: 35121487
[TBL] [Abstract][Full Text] [Related]
22. Characterization of gait variability in multiple system atrophy and Parkinson's disease.
Sidoroff V; Raccagni C; Kaindlstorfer C; Eschlboeck S; Fanciulli A; Granata R; Eskofier B; Seppi K; Poewe W; Willeit J; Kiechl S; Mahlknecht P; Stockner H; Marini K; Schorr O; Rungger G; Klucken J; Wenning G; Gaßner H
J Neurol; 2021 May; 268(5):1770-1779. PubMed ID: 33382439
[TBL] [Abstract][Full Text] [Related]
23. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.
Elsworth JD; Taylor JR; Sladek JR; Collier TJ; Redmond DE; Roth RH
Neuroscience; 2000; 95(2):399-408. PubMed ID: 10658619
[TBL] [Abstract][Full Text] [Related]
24. Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration.
Pothakos K; Kurz MJ; Lau YS
BMC Neurosci; 2009 Jan; 10():6. PubMed ID: 19154608
[TBL] [Abstract][Full Text] [Related]
25. Abnormalities in the stride length-cadence relation in parkinsonian gait.
Morris M; Iansek R; Matyas T; Summers J
Mov Disord; 1998 Jan; 13(1):61-9. PubMed ID: 9452328
[TBL] [Abstract][Full Text] [Related]
26. Gait dynamics in Parkinson's disease: relationship to Parkinsonian features, falls and response to levodopa.
Schaafsma JD; Giladi N; Balash Y; Bartels AL; Gurevich T; Hausdorff JM
J Neurol Sci; 2003 Aug; 212(1-2):47-53. PubMed ID: 12809998
[TBL] [Abstract][Full Text] [Related]
27. Gait Deficits and Loss of Striatal Tyrosine Hydroxlase/Trk-B are Restored Following 7,8-Dihydroxyflavone Treatment in a Progressive MPTP Mouse Model of Parkinson's Disease.
Massaquoi MS; Liguore WA; Churchill MJ; Moore C; Melrose HL; Meshul CK
Neuroscience; 2020 May; 433():53-71. PubMed ID: 32142862
[TBL] [Abstract][Full Text] [Related]
28. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS
Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824
[TBL] [Abstract][Full Text] [Related]
29. Network-wide oscillations in the parkinsonian state: alterations in neuronal activities occur in the premotor cortex in parkinsonian nonhuman primates.
Wang J; Johnson LA; Jensen AL; Baker KB; Molnar GF; Johnson MD; Vitek JL
J Neurophysiol; 2017 Jun; 117(6):2242-2249. PubMed ID: 28228579
[TBL] [Abstract][Full Text] [Related]
30. A quantitative approach to developing Parkinsonian monkeys (Macaca fascicularis) with intracerebroventricular 1-methyl-4-phenylpyridinium injections.
Li H; Lei X; Huang B; Rizak JD; Yang L; Yang S; Wu J; Lü L; Wang J; Yan T; Li H; Wang Z; Hu Y; Le W; Deng X; Li J; Xu L; Zhang B; Hu X
J Neurosci Methods; 2015 Aug; 251():99-107. PubMed ID: 26003862
[TBL] [Abstract][Full Text] [Related]
31. The effects of additional arm weights on arm-swing magnitude and gait patterns in Parkinson's disease.
Yoon J; Park J; Park K; Jo G; Kim H; Jang W; Kim JS; Youn J; Oh ES; Kim HT; Youm CH
Clin Neurophysiol; 2016 Jan; 127(1):693-697. PubMed ID: 26183756
[TBL] [Abstract][Full Text] [Related]
32. Fear of Falling Does Not Influence Dual-Task Gait Costs in People with Parkinson's Disease: A Cross-Sectional Study.
Prell T; Uhlig M; Derlien S; Maetzler W; Zipprich HM
Sensors (Basel); 2022 Mar; 22(5):. PubMed ID: 35271176
[TBL] [Abstract][Full Text] [Related]
33. Continuous MPTP intoxication in the Göttingen minipig results in chronic parkinsonian deficits.
Nielsen MS; Glud AN; Møller A; Mogensen P; Bender D; Sørensen JC; Doudet D; Bjarkam CR
Acta Neurobiol Exp (Wars); 2016; 76(3):199-211. PubMed ID: 27685773
[TBL] [Abstract][Full Text] [Related]
34. The validity of the GaitRite and the Functional Ambulation Performance scoring system in the analysis of Parkinson gait.
Nelson AJ; Zwick D; Brody S; Doran C; Pulver L; Rooz G; Sadownick M; Nelson R; Rothman J
NeuroRehabilitation; 2002; 17(3):255-62. PubMed ID: 12237507
[TBL] [Abstract][Full Text] [Related]
35. D(1) dopamine receptor agonists are more effective in alleviating advanced than mild parkinsonism in 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine-treated monkeys.
Goulet M; Madras BK
J Pharmacol Exp Ther; 2000 Feb; 292(2):714-24. PubMed ID: 10640310
[TBL] [Abstract][Full Text] [Related]
36. L-DOPA-induced behavioral sensitization of motor activity in the MPTP-treated common marmoset as a Parkinson's disease model.
Ando K; Inoue T; Itoh T
Pharmacol Biochem Behav; 2014 Dec; 127():62-9. PubMed ID: 25449794
[TBL] [Abstract][Full Text] [Related]
37. Profiling changes in gait dynamics resulting from progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal lesioning.
Goldberg NR; Hampton T; McCue S; Kale A; Meshul CK
J Neurosci Res; 2011 Oct; 89(10):1698-706. PubMed ID: 21748776
[TBL] [Abstract][Full Text] [Related]
38. Dissonance in Music Impairs Spatial Gait Parameters in Patients with Parkinson's Disease.
Fritz TH; Liebau G; Löhle M; Hartjen B; Czech P; Schneider L; Sehm B; Kotz SA; Ziemssen T; Storch A; Villringer A
J Parkinsons Dis; 2021; 11(1):363-372. PubMed ID: 33285641
[TBL] [Abstract][Full Text] [Related]
39. Gait in Huntington's disease and the stride length-cadence relationship.
Danoudis M; Iansek R
BMC Neurol; 2014 Oct; 14():161. PubMed ID: 25265896
[TBL] [Abstract][Full Text] [Related]
40. Effect of Bout Length on Gait Measures in People with and without Parkinson's Disease during Daily Life.
Shah VV; McNames J; Harker G; Mancini M; Carlson-Kuhta P; Nutt JG; El-Gohary M; Curtze C; Horak FB
Sensors (Basel); 2020 Oct; 20(20):. PubMed ID: 33053703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
